Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Steffi Oesterreich

Showing results (1-10 of 231) with videos related to

Pageof 24
Sort By:
Journal of Cellular Biochemistry|October 31, 2003
Scaffold attachment factors SAFB1 and SAFB2: Innocent bystanders or critical players in breast tumorigenesis?Steffi Oesterreich
Idrugs : the Investigational Drugs Journal|February 4, 2010
San Antonio breast cancer symposium--32nd annual meetingSteffi Oesterreich
Breast Cancer Research : BCR|July 1, 2005
Estrogen-repressed genes -- key mediators of estrogen action?Simeen Zubairy, Steffi Oesterreich
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|June 16, 2018
Heterogeneity in Metastatic Breast Cancer <sup>18</sup>F-Fluoroestradiol Uptake: Clinically Actionable, Biologically Illuminating?Brenda F Kurland, Steffi Oesterreich
Nature Genetics|November 26, 2013
The search for ESR1 mutations in breast cancerSteffi Oesterreich, Nancy E Davidson
Journal of Cellular Biochemistry|December 17, 2009
SAFB1's multiple functions in biological control-lots still to be done!Jason P Garee, Steffi Oesterreich
Cancer Immunology Research|February 24, 2023
Senescence and Immunotherapy: Redundant Immunomodulatory Pathways Promote ResistanceSteffi Oesterreich, Katherine M Aird
Aging|April 6, 2011
The Werner syndrome helicase protein is required for cell proliferation, immortalization, and tumorigenesis in Scaffold attachment factor B1 deficient miceSophie Lachapelle, Steffi Oesterreich, Michel Lebel
Cell Cycle (Georgetown, Tex.)|May 28, 2013
Progestins: pro-senescence therapy for ovarian cancer?Steffi Oesterreich, Robert Edwards, Anda Vlad
Journal of Mammary Gland Biology and Neoplasia|January 27, 2010
Epigenetic regulation in estrogen receptor positive breast cancer--role in treatment responseThushangi N Pathiraja, Vered Stearns, Steffi Oesterreich
Pageof 24

Showing results (1-10 of 231) with videos related to

Sort By:
Pageof 24
Journal of Cellular Biochemistry|October 31, 2003
Scaffold attachment factors SAFB1 and SAFB2: Innocent bystanders or critical players in breast tumorigenesis?Steffi Oesterreich
Idrugs : the Investigational Drugs Journal|February 4, 2010
San Antonio breast cancer symposium--32nd annual meetingSteffi Oesterreich
Breast Cancer Research : BCR|July 1, 2005
Estrogen-repressed genes -- key mediators of estrogen action?Simeen Zubairy, Steffi Oesterreich
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|June 16, 2018
Heterogeneity in Metastatic Breast Cancer <sup>18</sup>F-Fluoroestradiol Uptake: Clinically Actionable, Biologically Illuminating?Brenda F Kurland, Steffi Oesterreich
Nature Genetics|November 26, 2013
The search for ESR1 mutations in breast cancerSteffi Oesterreich, Nancy E Davidson
Journal of Cellular Biochemistry|December 17, 2009
SAFB1's multiple functions in biological control-lots still to be done!Jason P Garee, Steffi Oesterreich
Cancer Immunology Research|February 24, 2023
Senescence and Immunotherapy: Redundant Immunomodulatory Pathways Promote ResistanceSteffi Oesterreich, Katherine M Aird
Aging|April 6, 2011
The Werner syndrome helicase protein is required for cell proliferation, immortalization, and tumorigenesis in Scaffold attachment factor B1 deficient miceSophie Lachapelle, Steffi Oesterreich, Michel Lebel
Cell Cycle (Georgetown, Tex.)|May 28, 2013
Progestins: pro-senescence therapy for ovarian cancer?Steffi Oesterreich, Robert Edwards, Anda Vlad
Journal of Mammary Gland Biology and Neoplasia|January 27, 2010
Epigenetic regulation in estrogen receptor positive breast cancer--role in treatment responseThushangi N Pathiraja, Vered Stearns, Steffi Oesterreich
Pageof 24